Delivery Order SPE2DB24D2109-SPE2DB25FHWFE
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, and has a ceiling value of $3,248.94. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medication. The contract has a ceiling value of $3,140.40 and a performance period ending on August 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $63,817.20 firm fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,098.44 firm fixed-price contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty medication. The contract has a completion date of November 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, with a ceiling value of $1,069.63 and a performance period through March 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a larger...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,821.73, is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,324.90 and an ultimate completion date of January 31, 2025. The contract is for the procurement of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, with a ceiling value of $5,250.63 and a completion date of November 14, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. The $71,858.16 contract has an ultimate completion date of January 31, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,304.61, is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a type of medication. The contract is a firm fixed price contract with a period of performance ending on March 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...